We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+19.48%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$1.92B
AUM Growth
+$31.9M
Cap. Flow
-$110M
Cap. Flow %
-5.73%
Top 10 Hldgs %
20.76%
Holding
261
New
22
Increased
55
Reduced
94
Closed
33

Top Buys

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$14.8M
2
LITE icon
Lumentum
LITE
+$12M
3
VKTX icon
Viking Therapeutics
VKTX
+$10.7M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$8.6M
5
QTWO icon
Q2 Holdings
QTWO
+$8.19M

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$39.1M
2
IMGN
Immunogen Inc
IMGN
+$35.2M
3
CBAY
Cymabay Therapeutics
CBAY
+$20.7M
4
PRVA icon
Privia Health
PRVA
+$13.5M
5
SMPL icon
Simply Good Foods
SMPL
+$12.5M

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Healthcare 23.99%
3 Industrials 19.35%
4 Financials 12.43%
5 Consumer Discretionary 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONTO icon
26
Onto Innovation
ONTO
$13.4B
$22.5M 1.17%
124,501
-1,827
-1% -$309K
NVEE
27
DELISTED
NV5 Global
NVEE
$22.5M 1.17%
917,872
-42,992
-4% -$1.12M
MTSI icon
28
MACOM Technology Solutions
MTSI
$23B
$22M 1.15%
230,080
– –
MC icon
29
Moelis & Co
MC
$4.98B
$21.6M 1.13%
380,711
– –
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$21.6M 1.12%
312,131
+31,542
+11% +$2.17M
FORM icon
31
FormFactor
FORM
$9B
$21.2M 1.1%
464,841
– –
BWIN
32
Baldwin Insurance Group
BWIN
$2.77B
$21.2M 1.1%
732,113
+1,629
+0.2% +$42.8K
AIR icon
33
AAR Corp
AIR
$5.89B
$20.4M 1.06%
339,988
– –
MDGL icon
34
Madrigal Pharmaceuticals
MDGL
$11.8B
$20.2M 1.05%
75,759
+36,479
+93% +$8.6M
FOUR icon
35
Shift4
FOUR
$3.44B
$20M 1.04%
303,000
-99,554
-25% -$7.49M
COLL icon
36
Collegium Pharmaceutical
COLL
$944M
$19.8M 1.03%
511,201
-40,593
-7% -$1.42M
VKTX icon
37
Viking Therapeutics
VKTX
$3.88B
$19.7M 1.03%
+240,437
New +$10.7M
SVV icon
38
Savers
SVV
$1.68B
$18.9M 0.98%
980,669
+50,514
+5% +$943K
AX icon
39
Axos Financial
AX
$5.78B
$18.9M 0.98%
348,910
+49,625
+17% +$2.61M
ARHS icon
40
Arhaus
ARHS
$1.37B
$18M 0.94%
1,170,567
– –
RARE icon
41
Ultragenyx Pharmaceutical
RARE
$2.55B
$18M 0.94%
385,340
– –
LPX icon
42
Louisiana-Pacific
LPX
$5.31B
$17.3M 0.9%
+205,949
New +$14.8M
HLI icon
43
Houlihan Lokey
HLI
$8.92B
$17M 0.89%
132,870
-3,930
-3% -$486K
RMBS icon
44
Rambus
RMBS
$10.6B
$16.8M 0.87%
271,430
-24,136
-8% -$1.53M
FA icon
45
First Advantage
FA
$4.14B
$16.6M 0.86%
1,021,242
– –
PI icon
46
Impinj
PI
$5.25B
$16.5M 0.86%
128,202
+29,546
+30% +$3.1M
TMCI icon
47
Treace Medical Concepts
TMCI
$284M
$16M 0.84%
1,229,128
+45,189
+4% +$602K
BBIO icon
48
BridgeBio Pharma
BBIO
$16.2B
$15.5M 0.81%
500,254
– –
AGYS icon
49
Agilysys
AGYS
$3.03B
$15.2M 0.79%
180,533
+11,225
+7% +$907K
NOG icon
50
Northern Oil and Gas
NOG
$2.21B
$15.2M 0.79%
382,705
+1,319
+0.3% +$46.8K
1
2
3 4 5

Similar funds

SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
YC
Yarbrough Capital Franklin, Tennessee $2.85B AUM 36.22% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's Q1 2024 Portfolio in Review

As of Q1 2024, Emerald Mutual Fund Advisers Trust held 261 positions worth $1.92B, up 1.7% from $1.89B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Mutual Fund Advisers Trust withdrew a net $110M in Q1 2024, closing 33 positions and reducing 94 holdings. Its most notable exit was Immunogen Inc, an estimated $35.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Emerald Mutual Fund Advisers Trust opened a new position in Louisiana-Pacific worth $17.3M.

  • Emerald Mutual Fund Advisers Trust's largest Q1 2024 buy was Louisiana-Pacific: 205,949 shares worth $17.3M.
  • Emerald Mutual Fund Advisers Trust added most to Madrigal Pharmaceuticals in Q1 2024, an estimated $8.6M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $39.1M.
  • Emerald Mutual Fund Advisers Trust fully exited Immunogen Inc in Q1 2024, selling an estimated $35.2M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 21% of its $1.92B portfolio in Q1 2024.
  • Emerald Mutual Fund Advisers Trust opened 22 new positions and closed 33 in Q1 2024.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 1.7% quarter-over-quarter to $1.92B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2024, filed 8 May 2024.